The collaboration will leverage Genesis' GEMS or Genesis Exploration of Molecular Space artificial intelligence or AI platform to discover and optimize novel therapeutics for Incyte-selected targets.
The company’s fifty day moving average price ... of Genesis Energy by 2.9% during the 3rd quarter. Captrust Financial Advisors now owns 31,720 shares of the pipeline company’s stock valued ...
“Partnering with Genesis Therapeutics presents a unique opportunity to leverage their AI technologies to accelerate the discovery of breakthrough small molecules for high-impact targets in our ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback